Shanghai World Leader Pharmaceutical Co., Ltd.

This early-stage study tests a new nasal spray form of semaglutide (a weight-loss drug) in 60 overweight or obese adults. The main goal is to check safety and how the body processes the drug, not to prove weight loss yet. Participants receive a single dose and are monitored close…